You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thyroid hormone receptor agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • ASC41 2 mg
  • +2 more
  • (no location specified)
Jan 30, 2023

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Greenville (eneboparatide, Placebo)

Not yet recruiting
  • Chronic Hypoparathyroidism
  • +2 more
  • eneboparatide
  • Placebo
  • Greenville, North Carolina
    Physician's East Endocrinology
Mar 9, 2023

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Breast Cancer Trial in Worldwide (GDC-0810, LHRH Agonist, Palbociclib)

Terminated
Has Results
  • Breast Cancer
  • San Diego, California
  • +13 more
May 25, 2021

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Improvement of Laboratory Diagnostics in Hypothyroid Patients

Recruiting
  • Hypothyroidism
  • Single extra blood draw and completion of single questionnaire
  • Single blood draw and completion of single questionnaire
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Oct 12, 2023

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
Apr 30, 2021

Healthy Volunteer Trial in San Antonio (ASC43F)

Completed
  • Healthy Volunteer
  • San Antonio, Texas
    8307 Gault Lane
Dec 16, 2021

Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

Recruiting
  • Breast Cancer Recurrent
  • Palbociclib 125mg
  • Standard endocrine therapy
  • Graz, Austria
  • +52 more
Nov 15, 2022

Drug Safety Trial in Bengbu (RJ4287, Placebo)

Not yet recruiting
  • Drug Safety
  • Bengbu, Anhui, China
    The First Affiliated Hospital of Bengbu Medical College
Jun 25, 2023

Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)

Recruiting
  • Heart Failure
  • Thyroid hormone T3
  • Control Group
  • Atlanta, Georgia
  • +1 more
Nov 14, 2022

Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)

Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Tucson, Arizona
  • +145 more
Jan 17, 2023

Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Fulvestrant plus AI plus ribociclib
  • AI plus ribociclib
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Apr 16, 2023

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Prostate Cancer Trial in United States (ARN-509, LHRH Agonist)

Completed
Has Results
  • Prostate Cancer
  • Scottsdale, Arizona
  • +4 more
Feb 27, 2020

Multinodular Goiter Trial in Worldwide (Placebo, MRrhTSH)

Completed
  • Multinodular Goiter
  • Boston, Massachusetts
  • +10 more
Jun 3, 2022

Insulin Resistance, Diabetes, Abnormal Glucose Metabolism Trial run by the NIDDK (Liothyronine)

Completed
Has Results
  • Insulin Resistance
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 12, 2019

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

Healthy Volunteers Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Propranolol,

Recruiting
  • Healthy Volunteers
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022